Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNP | P00491 | 3/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.45 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | TK1 | P04183 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.41 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.41 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.41 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.40 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.40 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL195548 | 1.00 | PNP (0.55) | PNPCYP3A4MAPTADRB1DNMT1 | |
| SCHEMBL21779018 | 1.00 | PNP (0.55) | PNPCYP3A4MAPTADRB1DNMT1 | |
| Phosphoric Acid SCHEMBL9013988 | 0.96 | PNP (0.52) | PNPCYP3A4MAPTADRB1DNMT1 | |
| SCHEMBL655857 | 0.90 | PNP (0.65) | PNPCYP3A4MAPTADRB1DNMT1 | |
| SCHEMBL655858 | 0.90 | PNP (0.65) | PNPCYP3A4MAPTADRB1DNMT1 | |
| Citric Acid SCHEMBL3066161 | 0.89 | PNP (0.46) | PNPCYP3A4MAPTADRB1DNMT1 | |
| SCHEMBL3868526 | 0.88 | PNP (0.54) | PNPCYP3A4MAPTADRB1DNMT1 | |
| SCHEMBL13351290 | 0.88 | PNP (0.54) | PNPCYP3A4MAPTADRB1DNMT1 | |
| SCHEMBL18723297 | 0.88 | PNP (0.54) | PNPCYP3A4MAPTADRB1DNMT1 | |
| SCHEMBL14543297 | 0.88 | PNP (0.54) | PNPCYP3A4MAPTADRB1DNMT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 8544 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122036979-A | Extraction method of chicory aerial part polysaccharide, and related application and evaluation method | 金木集团有限公司 | 2026-05-15 | — | — | CN | claimed |
| CN-122012716-A | Tumor early detection method and system based on DNA features | 深圳市本源生物科技有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-12577554-B2 | Methods for purification of messenger RNA | TRANSLATE BIO, INC. (US) | 2026-03-17 | — | — | US | claimed |
| EP-4705468-A1 | MAMMALIAN POLYCISTRONIC EXPRESSION SYSTEM FOR DIRECT TRANSLATION FROM RNA AND SECRETION OF CARGO | California Institute of Technology (US) | 2026-03-11 | — | — | EP | claimed |
| US-12569572-B2 | Messenger RNA therapy for the treatment of Friedreich's ataxia | TRANSLATE BIO, INC. (US) | 2026-03-10 | — | — | US | claimed |
| US-20260028616-A1 | METHODS AND APPARATUS FOR DUPLEX NUCLEOTIDE PURIFICATION | AGILENT TECHNOLOGIES, INC. (US) | 2026-01-29 | — | — | US | claimed |
| EP-4677078-A1 | MANUFACTURE OF MESSENGER RNA WITH KP34 POLYMERASE | Sanofi Pasteur Inc. (US) | 2026-01-14 | — | — | EP | claimed |
| US-12509698-B2 | Synthesis and structure of high potency RNA therapeutics | ARCTURUS THERAPEUTICS, INC. (US) | 2025-12-30 | — | — | US | claimed |
| US-12473596-B2 | Delaying real-time sequencing | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2025-11-18 | — | — | US | claimed |
| US-20250325498-A1 | 8-OHdG CONCENTRATION DECREASE ACCELERATOR, MALONDIALDEHYDE (MDA) CONCENTRATION DECREASE ACCELERATOR, ZIP4 CONCENTRATION INCREASE ACCELERATOR, OR SERUM ZINC CONCENTRATION INCREASE ACCELERATOR FOR JEJUNUM | WATANABE OYSTER LABORATORY, CO., LTD. (JP) | 2025-10-23 | — | — | US | claimed |
| WO-2003016527-A2 | PROCESS FOR THE DETECTION OF OXIDATIVE STRESS AND KIT FOR ITS IMPLEMENTATION | PROBIOX SA (BE) | 2003-02-27 | — | — | WO | claimed |
| EP-1267162-A1 | SIMPLE METHOD OF BIOLOGICALLY EVALUATING NATURAL AND ARTIFICIAL CHEMICALS BY USING DNA INJURY INDEX AND APPARATUS THEREFOR | Ecological Technology Research, Ltd. (JP) | 2002-12-18 | — | — | EP | claimed |
| US-5950634-A | PREPARING A CHART FOR ASSESSING OXIDATIVE STRESS WHEREIN NUMERICAL FIGURE REPRESENTING THE DEGREE OF EXCESS OR DEFICIENCY OF AN INDICATOR SUBSTANCE INDICATING OXIDATIVE STRESS IN HUMANS | NIKKEN FOODS CO., LTD. (JP) | 1999-09-14 | — | — | US | claimed |
| EP-0767842-A1 | METHODS OF SCREENING FOR NUCLEOSIDE ANALOGS THAT ARE INCORPORATED BY HIV REVERSE TRANSCRIPTASE AND CAUSE INCORRECT BASE PAIRING | DARWIN MOLECULAR CORPORATION (US) | 1997-04-16 | — | — | EP | claimed |
| WO-1996000797-A1 | METHODS OF SCREENING FOR NUCLEOSIDE ANALOGS THAT ARE INCORPORATED BY HIV REVERSE TRANSCRIPTASE AND CAUSE INCORRECT BASE PAIRING | DARWIN MOLECULAR CORP (US) | 1996-01-11 | — | — | WO | claimed |
| US-5317013-A | Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1994-05-31 | — | — | US | claimed |
| US-4948730-A | INDUCING INTERFERON PRODUCTION | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1990-08-14 | — | — | US | claimed |
| US-4643992-A | Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1987-02-17 | — | — | US | claimed |
| EP-0112632-A2 | Use of 8-substituted guanine derivatives in the manufacture of a medicament. | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1984-07-04 | — | — | EP | claimed |
| WO-1984001898-A1 | MODULATION OF ANIMAL CELLULAR RESPONSES WITH COMPOSITIONS CONTAINNG 8-SUBSTITUTED GUANINE DERIVATIVES | SCRIPPS CLINIC RES (US) | 1984-05-24 | — | — | WO | claimed |